Physician profile
Omdevasena Thirugnanam
NPI 1245434240
$6,846.44
in general payments reported to CMS, 2019-2025
16 companies · $2,017 in 2025
The $2,017 reported for 2025 was more than what 85% of Sleep Medicine (Family Medicine) providers received nationally (typical 2025 total: $557).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $61.81 · 2020: $30.51 · 2021: $1,081 · 2022: $692 · 2023: $1,288 · 2024: $1,675 · 2025: $2,017.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,791 · Education: $190.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,790.78 |
| Education | $189.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Harmony Biosciences LLC | $1,965.56 | 2021-2025 | Wakix |
| Jazz Pharmaceuticals INC. | $1,635.87 | 2019-2025 | |
| Axsome Therapeutics, INC. | $897.69 | 2022-2025 | Sunosi |
| Idorsia Pharmaceuticals US INC | $696.79 | 2022-2024 | Quviviq |
| Zoll Respicardia, INC. | $503.07 | 2021-2024 | Remede System |
| Inspire Medical Systems, INC. | $400.49 | 2022-2025 | Inspire |
| Lilly USA, LLC | $247.38 | 2025 | Zepbound |
| Avadel Cns Pharmaceuticals, LLC | $172.54 | 2025 | Lumryz |
| Vanda Pharmaceuticals INC. | $94.12 | 2022-2023 | Hetlioz |
| Fisher & Paykel Healthcare INC | $76.54 | 2022-2024 | Fisher & Paykel Healthcare |
| Merck Sharp & Dohme LLC | $43.41 | 2022-2023 | Belsomra |
| Genzyme Corporation | $39.19 | 2021-2022 | |
| Itamar Medical INC | $23.57 | 2024 | Watchpatone |
| Novo Nordisk INC | $22.70 | 2025 | Wegovy |
| Azurity Pharmaceuticals, INC. | $16.20 | 2023 | Horizant |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $11.32 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Omdevasena Thirugnanam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.